Form 4: AdaptHealth Director Acquires Restricted Stock Units

AdaptHealth Director Gregory Belinfanti acquired 11,776 restricted stock units, increasing his direct beneficial ownership to 85,270 shares.

Summary

• Gregory Belinfanti, a Director of AdaptHealth Corp. (AHCO), acquired 11,776 shares of common stock.
• The acquisition occurred on January 9, 2026.
• These shares represent restricted stock units (RSUs) and will be settled in common stock upon vesting.
• The acquisition price was $0, which is typical for RSU grants.
• Following this transaction, Belinfanti directly beneficially owns 85,270 shares of AdaptHealth common stock.
• A Power of Attorney, dated February 19, 2025, authorizes Richard Rew and Shannone Raybon to file SEC reports on Belinfanti's behalf.

Sentiment

Score: 7

Explanation: The acquisition of restricted stock units by a director is generally a positive signal, indicating alignment of interests and confidence in the company's future. It's a routine compensation event, not a major strategic announcement, hence a moderate positive score.

Positives

• Director Gregory Belinfanti increased his beneficial ownership in AdaptHealth Corp. by acquiring 11,776 restricted stock units.
• The acquisition of restricted stock units aligns the director's interests with long-term shareholder value, as these units typically vest over time.

Risks

• The value of the restricted stock units is tied to the future performance of AdaptHealth's common stock, exposing the director to market fluctuations.

Future Outlook

The filing does not provide a general future outlook for the company, but the acquisition of restricted stock units implies a future vesting schedule that aligns the director's interests with long-term company performance.

Industry Context

Insider acquisitions of restricted stock units are a common form of equity compensation in publicly traded companies across various industries, including healthcare services like AdaptHealth. This practice aims to align management and director incentives with long-term shareholder value.

Comparison to Industry Standards

• The grant of restricted stock units (RSUs) to directors is a standard practice in corporate compensation across industries, including healthcare. Companies like LHC Group (LHCG) and Amedisys (AMED) also utilize equity-based compensation to incentivize directors and executives.
• A $0 acquisition price for RSUs is typical, as these represent a right to receive shares upon meeting vesting conditions, rather than a direct purchase.
• The increase in beneficial ownership by a director is generally viewed positively, signaling confidence in the company's future prospects, consistent with practices at peers.

Corporate Governance

Stakeholder Impact

• Shareholders: The increase in director ownership through RSUs can be viewed positively, as it aligns the director's financial interests with long-term shareholder value.

Next Steps

• The restricted stock units will be settled in common stock upon vesting, according to their specific vesting schedule (not detailed in this filing).

Key Dates

Recommendation

This Form 4 filing reports a routine grant of restricted stock units to a director, which is a standard form of equity compensation. While it indicates continued alignment of the director's interests with the company's long-term performance, it does not provide new fundamental information that would warrant a change in investment recommendation. It's a neutral event in terms of immediate stock valuation, suggesting a "hold" position for existing investors.

Keywords

AdaptHealth Corp., AHCO, Gregory Belinfanti, Form 4, Insider Transaction, Restricted Stock Units, RSU, Director, Beneficial Ownership, Equity Compensation